Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
40
COR Quote, Financials, Valuation and Earnings
Last price:
$346.09
Seasonality move
:
5.41%
Day range:
$329.10 - $341.72
52-week range:
$227.95 - $377.54
Dividend yield:
0.66%
P/E ratio:
42.87x
P/S ratio:
0.21x
P/B ratio:
43.86x
Volume:
1.6M
Avg. volume:
1.4M
1-year change:
48.74%
Market cap:
$66.1B
Revenue:
$321.3B
EPS (TTM):
$7.95
Analysts' Opinion
-
Consensus RatingCencora, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $387.93, Cencora, Inc. has an estimated upside of 13.79% from its current price of $340.92.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $315.00 representing 100% downside risk from its current price of $340.92.
Fair Value
-
According to the consensus of 14 analysts, Cencora, Inc. has 13.79% upside to fair value with a price target of $387.93 per share.
COR vs. S&P 500
-
Over the past 5 trading days, Cencora, Inc. has underperformed the S&P 500 by -0.86% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Cencora, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cencora, Inc. has grown year-over-year revenues for 52 quarters straight. In the most recent quarter Cencora, Inc. reported revenues of $83.7B.
Earnings Growth
-
Cencora, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Cencora, Inc. reported earnings per share of -$1.75.
Enterprise value:
71.3B
EV / Invested capital:
--
Price / LTM sales:
0.21x
EV / EBIT:
19.55x
EV / Revenue:
0.22x
PEG ratio (5yr expected):
7.21x
EV / Free cash flow:
22.24x
Price / Operating cash flow:
20.71x
Enterprise value / EBITDA:
15.15x
Gross Profit (TTM):
$10.1B
Return On Assets:
2.19%
Net Income Margin (TTM):
0.49%
Return On Equity:
124.72%
Return On Invested Capital:
17.24%
Operating Margin:
1.02%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $262.2B | $294B | $321.3B | $79.1B | $83.7B | |
| Gross Profit | $7.8B | $8.7B | $10.1B | $2.2B | $2.6B | |
| Operating Income | $2.4B | $3B | $3.6B | $672.9M | $854.6M | |
| EBITDA | $3.4B | $4.1B | $4.7B | $951M | $1.1B | |
| Diluted EPS | $8.53 | $7.51 | $7.95 | $0.02 | -$1.75 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $38.8B | $39.6B | $42.8B | $47.7B | $52.2B | |
| Total Assets | $57.3B | $56.6B | $62.6B | $67.1B | $76.6B | |
| Current Liabilities | $41.4B | $43.5B | $48.8B | $54.3B | $57.8B | |
| Total Liabilities | $56.8B | $56.5B | $61.9B | $66.3B | $74.8B | |
| Total Equity | $584.4M | $71.3M | $666.3M | $786.7M | $1.7B | |
| Total Debt | $7.6B | $5.7B | $5.7B | $5.4B | $9.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $3.9B | $3.5B | $3.9B | $1B | $3.1B | |
| Cash From Investing | -$2.6B | -$618.1M | -$5B | -$241.9M | -$321.9M | |
| Cash From Financing | -$2.2B | -$2.3B | $2.2B | -$957.3M | -$683.8M | |
| Free Cash Flow | $3.5B | $3B | $3.2B | $818.1M | $2.9B | |
COR
Sector
Market Cap
$66.1B
$28.1M
Price % of 52-Week High
90.3%
50.9%
Dividend Yield
0.66%
0%
Shareholder Yield
-0.14%
-1.55%
1-Year Price Total Return
48.74%
-19.36%
Beta (5-Year)
0.664
0.498
Dividend yield:
0.66%
Annualized payout:
$2.20
Payout ratio:
15.62%
Growth streak:
20 years
Technicals
8-day SMA
Buy
Level
$339.93
200-day SMA
Buy
Level
$306.81
Bollinger Bands (100)
Buy
Level
299.54 - 351.68
Chaikin Money Flow
Buy
Level
473.3M
20-day SMA
Sell
Level
$341.10
Relative Strength Index (RSI14)
Sell
Level
46.22
ADX Line
Sell
Level
14.55
Williams %R
Neutral
Level
-48.3617
50-day SMA
Sell
Level
$348.63
MACD (12, 26)
Sell
Level
-2.37
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Neutral
Level
187.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.8706)
Sell
CA Score
(Annual)
Level (-0.7035)
Buy
Beneish M-Score
(Annual)
Level (-2.5377)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.8039)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.
Stock Forecast FAQ
In the current month, COR has received 10 Buy ratings 4 Hold ratings, and 0 Sell ratings. The COR average analyst price target in the past 3 months is $387.93.
-
Where Will Cencora, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cencora, Inc. share price will rise to $387.93 per share over the next 12 months.
-
What Do Analysts Say About Cencora, Inc.?
Analysts are divided on their view about Cencora, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cencora, Inc. is a Sell and believe this share price will drop from its current level to $315.00.
-
What Is Cencora, Inc.'s Price Target?
The price target for Cencora, Inc. over the next 1-year time period is forecast to be $387.93 according to 14 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is COR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cencora, Inc. is a Buy. 10 of 14 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of COR?
You can purchase shares of Cencora, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cencora, Inc. shares.
-
What Is The Cencora, Inc. Share Price Today?
Cencora, Inc. was last trading at $346.09 per share. This represents the most recent stock quote for Cencora, Inc.. Yesterday, Cencora, Inc. closed at $340.92 per share.
-
How To Buy Cencora, Inc. Stock Online?
In order to purchase Cencora, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get COR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
COR
Sector
P/E ratio
42.87x
24.09x
PEG ratio
7.21x
-0.01x
P/B ratio
43.86x
1.83x
Price / LTM sales
0.21x
1.59x
Growth Metrics
COR
Sector
Revenue growth
5.92%
4.68%
Earnings growth
-10345.61%
10.88%
Revenue (5-year growth)
11.09%
6.45%
Earnings forecast
$3.97
-$0.18
Profitability
COR
Sector
Profitability FY 2025
$10.1B
$3.6M
Return on invested capital
17.24%
-31.87%
Return on assets
2.19%
-28.18%
Return on equity
124.72%
-37.89%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Feb
4
Balance Sheet
COR
Sector
Total cash
$4.4B
$26.2M
Short term investments
--
$25.7M
Total assets
$76.6B
$76.7M
Long term debt
$9.1B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 36x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
64
RGC alert for Jan 6
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Buy
73
INOD alert for Jan 6
Innodata, Inc. [INOD] is up 4.84% over the past day.
Buy
65
AVAV alert for Jan 6
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
